Epitaz 50mg Injection is a medication containing the active ingredient Etanercept. Etanercept is a biologic drug that works by targeting and neutralizing a specific protein in the body called tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is a key player in the inflammatory process that contributes to various autoimmune diseases. By blocking TNF-alpha, Epitaz helps to reduce inflammation, pain, and joint damage associated with these conditions.
Epitaz 50mg Injection is indicated for the treatment of several chronic inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is typically used in patients who have not responded adequately to other treatments or who have severe forms of these diseases.
The usual dosage of Epitaz 50mg Injection is determined by a healthcare professional based on the specific condition being treated and the patient’s response. It is administered via subcutaneous injection. Common side effects may include injection site reactions (redness, swelling, itching), upper respiratory infections, headache, and nausea. Serious side effects, though rare, can include an increased risk of infections, allergic reactions, and certain types of cancer. Patients should discuss their medical history and any concerns with their doctor before starting treatment. Epitaz 50mg Injection should be stored at room temperature and protected from light.
